#1
|
||||
|
||||
10 çàâåòîâ èììóíèçàöèè
• Íå îòêàçûâàé â âàêöèíàöèè íè îäíîìó ðåáåíêó, èáî âñå äåòè èìåþò ïðàâî íà çàùèòó îò áîëåçíåé.
• Ïðîñâåòëÿé óìû òåõ, êòî íå èñïîëíÿåò ñâîåãî äîëãà ïî çàùèòå ïîòîìñòâà îò èíôåêöèé. • Ïåðåä âàêöèíàöèåé çàðó÷èñü ñîãëàñèåì ñâîåãî ïàöèåíòà. • Îòíîñèñü ê âàêöèíàì ïî÷òèòåëüíî, ñ áëàãîãîâåíèåì è îáðàùàéñÿ ñ íèìè áåðåæíî. • Íå áîéñÿ îäíîâðåìåííîãî ââåäåíèÿ íåñêîëüêèõ âàêöèí. • Íèêîãäà íå óìåíüøàé ðåêîìåíäóåìîé äîçû. • Íå íà÷èíàé êóðñ âàêöèíàöèè çàíîâî, åñëè êàêàÿ-ëèáî èç äîç áûëà ââåäåíà ñ çàïîçäàíèåì. • Íå îòêëàäûâàé íà çàâòðà âàêöèíàöèþ, êîòîðàÿ ìîãëà áûòü ïðîâåäåíà ñåãîäíÿ. • Áóäü îòêðûò ê èçìåíåíèÿì â êàëåíäàðå ïðèâèâîê è ïðèäåðæèâàéñÿ ðåêîìåíäóåìûõ ñïåöèàëèñòàìè ñõåì âàêöèíàöèè. • Íå çàáûâàé òåõ äíåé, êîãäà òâîè ïðåäêè ñòðàäàëè îò áîëåçíåé â îòñóòñòâèè âàêöèí. Dr. Thomas Nick Saari |
#2
|
|||
|
|||
> Íå áîéñÿ îäíîâðåìåííîãî ââåäåíèÿ íåñêîëüêèõ âàêöèí.
À êàê æå Ñîâðåìåííûå ïðîáëåìû âàêöèíîïðîôèëàêòèêè òóáåðêóëåçà Æ.È. Êðèâîøååâà,Í.Ñ. Ìîðîçêèíà,Ï.Ñ. Êðèâîíîñ Áåëîðóññêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò Ïðè èçó÷åíèè ðîññèéñêèìè ó÷åíûìè (Åôèìîâà À.À. ñ ñîàâò.) ãóìîðàëüíûõ ïîêàçàòåëåé êðîâè íîâîðîæäåííûõ äî è ïîñëå âàêöèíàöèè ÁÖÆ óñòàíîâëåíî, ÷òî ñâîáîäíûé ãèñòàìèí â ñûâîðîòêå êðîâè äåòåé äî ââåäåíèÿ âàêöèíû íå îáíàðóæèâàëñÿ, íî ÷åðåç 9-10 äíåé ïîñëå âàêöèíàöèè ñîäåðæàíèå ãèñòàìèíà â êðîâè çàìåòíî âîçðàñòàëî. Ïîêàçàòåëü ãèñòàìèíîñâÿçûâàþùåé ñïîñîáíîñòè ñûâîðîòêè êðîâè îñòàâàëñÿ íèçêèì èëè íóëåâûì â òå÷åíèå 2-3 ìåñÿöåâ, ó äåòåé ñ àëëåðãè÷åñêèìè çàáîëåâàíèÿìè – è áîëåå äëèòåëüíûé ñðîê, ÷òî ñîïðîâîæäàëîñü óñèëåíèåì ñèìïòîìîâ àëëåðãèè èëè âîçíèêíîâåíèåì èíòåðêóððåíòíûõ çàáîëåâàíèé. Âàêöèíàëüíûé ïðîöåññ ïîñòåïåííî íàðàñòàåò â òå÷åíèå 2-3 ìåñÿöåâ.  ýòî âðåìÿ ðåáåíêà âàêöèíèðóþò ïîâòîðíî â 1 ìåñÿö ïðîòèâ ãåïàòèòà  è â 3 ìåñÿöà åùå ïðîòèâ 4 èíôåêöèé äâóìÿ âàêöèíàìè, íå ïðèíèìàÿ âî âíèìàíèå ñòàäèþ ìåñòíîé ðåàêöèè íà ââåäåíèå âàêöèíû ÁÖÆ. Îïðåäåëåííàÿ ÷àñòü îñëîæíåíèé ñâÿçàíà êàê ðàç ñ ïðîâåäåíèåì äðóãèõ ïðèâèâîê íà ôîíå ëîêàëèçîâàííîãî, íî àêòèâíîãî òóáåðêóëåçíîãî ïðîöåññà â êîæå íà ìåñòå ââåäåíèÿ âàêöèíû ÁÖÆ [20]. 20. Òóáåðêóëåç ó äåòåé è ïîäðîñòêîâ: ðóêîâîäñòâî / ïîä ðåä. Î. È. Êîðîëü, Ì. Ý. Ëîçîâñêîé. ÑÏá: Ïèòåð, 2005. 432 ñ. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#3
|
||||
|
||||
Öèòàòà:
.
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#4
|
|||
|
|||
Ò.å. åñòü èññëåäîâàíèÿ, îïðîâåðãàþùèå Åôèìîâó è Êîðîëÿ?
|
#6
|
||||
|
||||
Ñïåöèàëüíî äëÿ Âàñ:
4. When appropriate, all indicated vaccines should be administered simultaneously (B-III). If >1 vaccine is recommended to be administered at a specific age, vaccines should be administered at the same visit at separate injection sites. Simultaneously administering all vaccines to a person who is eligible is important, because simultaneous administration increases the probability that a child or adult will be appropriately immunized [23]. ...Simultaneously administering different combinations of live and inactivated vaccines has resulted in seroconversion rates similar to rates observed when the vaccines are administered separately [22]. èñòî÷íèê ïîëíîãî òåêñòà çäåñü (òàì æå ññûëêè íà ïåðâîèñòî÷íèêè): [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#7
|
|||
|
|||
Áëàãîäàðþ.
 òåõ æå "Ñîâðåìåííûõ ïðîáëåìàõ..." çàìàõèâàþòñÿ è íà øåñòîé ïóíêò çàâåòîâ: Èñïîëüçîâàíèå âàêöèíû ÁÖÆ-Ì ñî ñíèæåííîé àíòèãåííîé íàãðóçêîé ïîçâîëèëî óìåíüøèòü ÷èñëî ÁÖÆ-ëèìôàäåíèòîâ â 3-5 ðàç [2, 14]. Âñå âûøåóêàçàííîå ïîçâîëÿåò ïðåäëîæèòü ìåðîïðèÿòèÿ, êîòîðûå, ïî íàøåìó ìíåíèþ, ïîâûñÿò ýôôåêòèâíîñòü è ñíèçÿò ðèñê ðàçâèòèÿ îñëîæíåíèé âàêöèíàöèè ÁÖÆ: - áîëåå øèðîêàÿ (èëè ñïëîøíàÿ) ùàäÿùàÿ èììóíèçàöèÿ âàêöèíîé ÁÖÆ-Ì. 2. Àêñåíîâà, Â. À. Ñîâðåìåííûå ïîäõîäû ê âàêöèíàöèè ïðîòèâ òóáåðêóëåçà [Ýëåêòðîííûé ðåñóðñ]. 14. Ëåãî÷íûé è âíåëåãî÷íûé òóáåðêóëåç: Ðóêîâîäñòâî äëÿ âðà÷åé / ïîä ðåä. À. Â. Âàñèëüåâà. ÑÏá., 2007. Äàííàÿ ðåêîìåíäàöèÿ òàêæå íåêîððåêòíà? |
|
#8
|
|||
|
|||
|
#9
|
||||
|
||||
Öèòàòà:
A comparative effectiveness of the newborn BCG- and BCG-M vaccination was analysed as to the indices of primary infection, morbidity and its structure. The rate of postvaccination complications in 1,645,360 children, aged under 3 years, and living in the areas with different epidemiological situations for tuberculosis was studied too. 2,142,292 and 799486 healthy newborns were BCG- and BCG-M-vaccinated, respectively. The studies were carried out in Moscow, Kiev, Vilnius and Tashkent. The obtained results indicate that the number of complications in the form of regional lymphadenitis induced by BCG-M vaccine is 5 times less frequent than those caused by BCG.//Probl Tuberk. 1990;(12):3-5.
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#10
|
|||
|
|||
Öèòàòà:
Îäíà àìïóëà ïðåïàðàòà âàêöèíû ÁÖÆ âìåñòèìîñòüþ 2 ìë ñîäåðæèò 1 ìã ëèîôèëèçèðîâàííîãî âàêöèííîãî øòàììà ÁÖÆ-1. Ïðèâèâî÷íàÿ äîçà 0,05 ìã ïðåïàðàòà.  àìïóëå ïðåïàðàòà ÁÖÆ-Ì ñîäåðæèòñÿ 0,5 ìã âàêöèííîãî øòàììà ÁÖÆ-1, à îäíà ïðèâèâî÷íàÿ äîçà ðàâíà 0,025 ìã ïðåïàðàòà. È ýôôåêòèâíîñòü äëÿ íåáëàãîïîëó÷íûõ ðàéîíîâ ñíèæàåòñÿ: Under favourable epidemiological conditions, the primary infection and morbidity are alike, while under unfavourable ones the former is higher, particularly in infants in their first year as compared to the BCG-vaccinated. On the basis of the available data BCG-M can be recommended for the vaccination of all the newborns living in the areas with a favourable epidemiological situation for tuberculosis |
#11
|
|||
|
|||
Öèòàòà:
È ÷èñòî àäìèíèñòðàòèâíûå çàìîðî÷êè: "and if uncertainty exists as to whether a person will return for additionally recommended vaccine doses". Ïîëó÷àåòñÿ, ïåðâîèñòî÷íèêè Ëîçîâñêîé è Êîðîëþ íå ïðîòèâîðå÷àò, âîïðîñ òîëüêî â òîì - äîâåðÿòü ëè èì (Ë&Ê). |
#12
|
||||
|
||||
Åñëè ýòî îäíà âàêöèíà, òî òåì áîëåå á0ëüøàÿ ãëóïîñòü ðàçíîñèòü èõ â ðàçíûå êîðîáî÷êè è íàçûâàòü ïî ðàçíîìó âìåñòî òîãî, ÷òîáû íàïèñàòü êàê ïðàâèëüíî äîçèðîâàòü äëÿ íîâîðîæäåííûõ... âîò âûäåðæêà èíñòðóêöèè ÁÖÆ îò Ìåðêà:
In infants less than 1 month old, the dosage of BCG VACCINE should be reduced by one-half, by using 2 mL of Sterile Water for Injection, U.S.P. at 4–25°C (39–77°F) when reconstituting. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] è íèêàêèõ ïîíòîâ ñ ÁÖÆ-Ì èëè "äîñòèæåíèå îòå÷åñòâåííîé íàó÷íîé ìûñëè"... çàìåòüòå, èíñòðóêöèÿ ïðîñòî ñîîáùàåò î íàçíà÷åíèè ïîëîâèííîé äîçû â äàííîé âîçðàñòíîé ãðóïïå äåòåé, íî íå ïðèçûâàåò ê ëèáåðàëüíîìó ñíèæåíèþ äîçû âàêöèíàöèè ïî óñìîòðåíèþ âðà÷à èëè ìåäðàáîòíèêà, ïðîâîäÿù. âàêöèíàöèþ...
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#13
|
|||
|
|||
Äà, åñòü íåêîòîðàÿ òîíêîñòü.
|
#14
|
|||
|
|||
Ìîæåò áûòü óâàæàåìàÿ luidhen ïîäåëèòñÿ - êàêèå èññëåäîâàíèÿ îïðîâåðãàþò Êîðîëÿ è Ê?
|
#15
|
|||
|
|||
Äëÿ íà÷àëà õîòåëîñü áû âèäåòü íå ññûëêó íà áåëîðóññêóþ ðàáîòó, ññûëàþùóþñÿ â ñâîþ î÷åðåäü íà ðàáîòó Î. Êîðîëü (îíà, êñòàòè, äàìà), à êîíêðåòíóþ ÷àñòü ðàáîòû óïîìÿíóòîãî àâòîðà, äîêàçûâàþùóþ, ÷òî "Îïðåäåëåííàÿ ÷àñòü îñëîæíåíèé ñâÿçàíà êàê ðàç ñ ïðîâåäåíèåì äðóãèõ ïðèâèâîê íà ôîíå ëîêàëèçîâàííîãî, íî àêòèâíîãî òóáåðêóëåçíîãî ïðîöåññà â êîæå íà ìåñòå ââåäåíèÿ âàêöèíû ÁÖÆ".
|